Opposite central cardiovascular effects of various morphine-like drugs and opiate peptides in the rat.
Opiate agonists were administered into the cisterna magna of normotensive urethane-anaesthetized artificially-ventilated rats. Increases in blood pressure and heart rate were produced by fentanyl (0.3-3.0 nmol). [D-ala]2-met-enkephalinamide (17 nmol), and beta-endorphin (2.9 nmol). On the contrary, ethylketocyclazocine (78.7 nmol) and dynorphin (1-13) (62.3 nmol) produced decreases in blood pressure and heart rate. The cardiovascular effects of ethylketocyclazocine and dynorphin (1-13) were antagonized by higher doses of naloxone than that required to counteract the effects of fentanyl. These results suggest that opposite central cardiovascular effects could be induced by activation of various opiate receptors.
D000818:Animals; D001794:Blood Pressure / Q000187:drug effects*; D001921:Brain / Q000187:drug effects*; D003496:Cyclazocine / Q000031:analogs & derivatives* / Q000494:pharmacology; D004399:Dynorphins; D004723:Endorphins / Q000494:pharmacology*; D004744:Enkephalin, Methionine / Q000031:analogs & derivatives / Q000494:pharmacology; D016314:Ethylketocyclazocine; D005283:Fentanyl / Q000494:pharmacology*; D006339:Heart Rate / Q000187:drug effects*; D008297:Male; D010446:Peptide Fragments / Q000494:pharmacology*; D051381:Rats; D011919:Rats, Inbred Strains
D004723:Endorphins; D010446:Peptide Fragments; D004744:Enkephalin, Methionine; D016314:Ethylketocyclazocine; C022118:enkephalinamide-Met, Ala(2)-; C026843:dynorphin (1-13); D004399:Dynorphins; D003496:Cyclazocine; D005283:Fentanyl